174.90 USD
-0.20
0.11%
At close Feb 4, 4:00 PM EST
After hours
174.90
+0.00
0.00%
1 day
-0.11%
5 days
-3.50%
1 month
-3.10%
3 months
-15.64%
6 months
-25.04%
Year to date
-2.32%
1 year
-28.35%
5 years
-54.37%
10 years
59.09%
 

About: Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Employees: 14,500

0
Funds holding %
of 6,831 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

99% more call options, than puts

Call options by funds: $5.07M | Put options by funds: $2.55M

50% more funds holding in top 10

Funds holding in top 10: 2 [Q2] → 3 (+1) [Q3]

33% more repeat investments, than reductions

Existing positions increased: 204 | Existing positions reduced: 153

20% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 55

8% more capital invested

Capital invested by funds: $10.3B [Q2] → $11.1B (+$772M) [Q3]

1% more funds holding

Funds holding: 515 [Q2] → 519 (+4) [Q3]

8.88% less ownership

Funds ownership: 103.79% [Q2] → 94.91% (-8.88%) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$200
14%
upside
Avg. target
$200
14%
upside
High target
$200
14%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Truist Securities
Richard Newitter
79% 1-year accuracy
33 / 42 met price target
14%upside
$200
Hold
Maintained
18 Dec 2024

Financial journalist opinion

Based on 3 articles about TFX published over the past 30 days

Neutral
GlobeNewsWire
3 weeks ago
Teleflex awarded Short Term Central Venous Catheters contract from Vizient
WAYNE, Pa., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has been awarded a contract by Vizient, Inc., the largest provider-driven healthcare performance improvement company in the U.S. The agreement, effective January 1, 2025, covers the supply of Teleflex's Central Venous Access Catheters and Arterial Catheters. Vizient provides solutions and services that improve the delivery of high-value care by aligning cost, quality, and market performance for more than 65% of the nation's acute care providers.
Teleflex awarded Short Term Central Venous Catheters contract from Vizient
Neutral
GlobeNewsWire
4 weeks ago
Teleflex to Present at the 43rd Annual J.P. Morgan Healthcare Conference
WAYNE, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 43rd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis in San Francisco, California, on Tuesday, January 14, 2025, at 5:15 p.m. (PT).
Teleflex to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Neutral
Business Wire
4 weeks ago
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)
NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Teleflex Incorporated (NYSE: TFX) concerning the Company and its directors' and officers' possible violations of state laws. If you own Teleflex stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230 Park Avenue, Suite 358, New York, NY 10169 at tkennedy.
Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)
Positive
Zacks Investment Research
1 month ago
Here's Why Teleflex (TFX) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Teleflex (TFX) is a Strong Value Stock
Positive
Zacks Investment Research
1 month ago
Should You Retain Teleflex Stock in Your Portfolio Right Now?
TFX stays on investors' radars due to its performance in the Vascular Access segment and expansion moves.
Should You Retain Teleflex Stock in Your Portfolio Right Now?
Positive
Zacks Investment Research
1 month ago
Teleflex Expands CVC Portfolio in EMEA With New Launch: Stock to Gain?
Teleflex introduces the Arrowg+ard Blue Plus MSB Procedure Kit in the EMEA.
Teleflex Expands CVC Portfolio in EMEA With New Launch: Stock to Gain?
Positive
Zacks Investment Research
1 month ago
Why Teleflex (TFX) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Teleflex (TFX) is a Top Value Stock for the Long-Term
Positive
Zacks Investment Research
2 months ago
Here's Why Teleflex (TFX) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Teleflex (TFX) is a Strong Growth Stock
Positive
Zacks Investment Research
2 months ago
Here's Why Teleflex (TFX) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Teleflex (TFX) is a Strong Value Stock
Neutral
GlobeNewsWire
2 months ago
Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference
WAYNE, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 36th Annual Piper Sandler Healthcare Conference at The Lotte New York Palace, New York, NY, on Tuesday, December 3, 2024, at 9:30 a.m. (ET).
Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference
Charts implemented using Lightweight Charts™